Profile of antimicrobial resistance in oncologic pediatric patients

  • Mauricio García-Luna Hospital General de Pachuca
  • José Antonio Madrid Gómez-Tagle Hospital del Niño DIF
  • Jessica P. O’Brien Escuela Americana de Pachuca
Keywords: Antimicrobial Resistance; Oncologic Patients; Children; Neutropenia.


The development of resistance to antibiotics is due to the widespread use of a wide variety of antimicrobials, coupled with the ability of bacteria to acquire and spread resistance and the ability of humans to disseminate them. The possible consequences of antimicrobial resistance leads to greater chances of hospitalization, prolongation of hospital stay and increased mortality. Furthermore, treatment of drug resistant bacteria requires the use of more toxic drugs and more expense for the patient and hospitals. The main objective of the present study was to determine the frequency and nature of antimicrobial resistance of microorganisms in oncologic and hematologic patients at a Mexican Pediatric Hospital. A retrospective, observational, and analytical study was realized, where we reviewed the clinical records of 20 cases. Blood cultures were obtained from the Laboratory of our institution from 2010 to 2011. The data obtained were organized and analyzed. We observed that the E. coli and S. aureus were the bacteria most resistant, showing the same percentage between gram-positive and gram-negative bacteria. The cancer diagnosis most common in our study was acute lymphoblastic leukemia. It may be concluded that multidrug-resistant bacteria in these patients are of a nosocomial origin, without a specific group of germ (gram positive vs. gram negative).


1. Dufort Alvarez G. Guía para el Tratamiento del Paciente con Neutropenia Febril. Arch Pediatr Urg 2009;80: 37-42.

2. Gaytan MJ, Mateos GE, Sánchez CE, González LJ, Casanova CL, Fuentes-Allen JL. Microbiological findings in febrile neutropenia. Arch Med Res 2000; 31: 388-92.

3. Santoya de P. ME, Rabagliati B. Consenso manejo racional del paciente con cáncer, neutropenia y fiebre. Rev Chil Infect2005; 22 (Supl 2): S79.

4. Gaytán-Martinez J, Ávila-Moran M, Mata-Marin JA. Patrones de suceptibilidad bacteriana en infecciones en pacientes adultos con neoplasias, hematológicas, fiebre y neutropenia. Gac Méd Méx 2011; 147: 325-32.

5. Freifeld AG, Walsh TJ, Pizzo PA. Infectious complications in the pediatric cancer patient. En: Pizzo PA, Poplack DG (eds.). Principles and practices in pediatric oncology. Philapdelphia: Lippincott-Raben Publisehrs, 1997:1069.

6. Rubin RH, Ferraro MJ. Understanding an diagnosing infectious complications in the immunocompromised host. Hematol Oncol Clin North Am 1988; 74:795-81013

7. Bodey GP. Patients with neutropénica: Old a new treatament modalities. Empirical antibiotic therapy for fever in neutropenic patients. Clin infect Dis 1993; 17( Suppl 2 ): S 378-384.

8. Rubin M, Hathorn JW, Pizzo PA. Controversies in the management of febrile neutropenic cancer patient. Cancer Investet 1998; 6: 167-184.

9. Pizzo PA, Commers JR, Cotton DJ. Approaching the controversies in the antibacterial management of cancer patient. Am J Med 1984; 76: 436-445.

10. Peterson LR. Apretando el globo de los antibióticos: efectos del uso de diversas clases de antimicrobianos sobre la aparición de resistencias Clin Microbiol infect (ed. cast). 2005; 11 Suppl 5: S4-16.

11. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001; 134: 298-314.

12. Rello J, Gallego M, Mariscal D. The Value of routine microbial investigation in ventilator associated pneumonia AM J Respir Crit Care Med 1997; 156:196-200.

13. Fernández Alonso R, González Garcia ME, Fernández García J. Profilaxis antimicrobiana en el paciente neutropénico. Rev Clin Esp 2004; 204(12): 645-8.

14. Bruckner L, Gigliotti S. Viridians Group Streptococcal Infections Among Children With Cancer and the importance of Emerging Antibiotic Resistance. Semin Pediatr Infect Disae 2006; 17(3):153-60.

15. Cheguirián ML, Carvajal LR, Ledesma EM, Enrico MC, Reale AL, Culasso C, et al; Prevalencia de microorganismos causantes de bacteriemias y fungemias en pacientes oncológicos pediátricos. Patrones de sensibilidad a los antimicrobianos. Rev. Argent. Microbiol. 2008; 40:111-115.

16. Casellas J. M. Informe del Comité de resistencias a Antibacterianos de la API, periodo 2003-2004. Rev Panamer Infect 2004, 6:4.

17. Torres Harrys A. Neutropenia Febril: una revisión del tema. En VITAE_3187.pdf . Acceso 12 enero 2012.